INVESTOR RELATIONS | MTI Ltd. (IR)

CEO Message

2025.01.21 Timely disclosure	Notice Regarding Issuance of New Shares as Restricted Stock Remuneration and Cancellation of Treasury Stock
2025.01.08 Information	Bridge Report: MTI Fiscal Year ended September 2024
2024.12.23 Timely disclosure	Notice of Consolidated Subsidiary (Pharmo Inc.)’s Capital Increase Through Third-Party Allotment of Shares
2024.12.23 Shareholders' meeting	Notice of Results of Voting Rights at the 29th Annual General Meeting of Shareholders
2024.12.23 Timely disclosure	Matters Concerning a Controlling Shareholder, etc.